ATE121293T1 - Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält. - Google Patents

Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Info

Publication number
ATE121293T1
ATE121293T1 AT91901713T AT91901713T ATE121293T1 AT E121293 T1 ATE121293 T1 AT E121293T1 AT 91901713 T AT91901713 T AT 91901713T AT 91901713 T AT91901713 T AT 91901713T AT E121293 T1 ATE121293 T1 AT E121293T1
Authority
AT
Austria
Prior art keywords
active ingredient
biological effect
intestinal mucosa
triglyceride
substance
Prior art date
Application number
AT91901713T
Other languages
English (en)
Inventor
Sven Froekjaer
Tomas Tage Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8148900&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE121293(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE121293T1 publication Critical patent/ATE121293T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91901713T 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält. ATE121293T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden

Publications (1)

Publication Number Publication Date
ATE121293T1 true ATE121293T1 (de) 1995-05-15

Family

ID=8148900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91901713T ATE121293T1 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Country Status (8)

Country Link
EP (1) EP0509009B1 (de)
JP (1) JPH05502669A (de)
AT (1) ATE121293T1 (de)
AU (1) AU638541B2 (de)
CA (1) CA2072010A1 (de)
DE (1) DE69018836T2 (de)
DK (2) DK657689D0 (de)
WO (1) WO1991009597A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466768B2 (de) * 1989-04-07 1999-06-30 New England Deaconess Hospital Corporation Kurzkettige triglyceride
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
DE69403789T2 (de) * 1993-04-23 1997-12-04 Loders Croklaan Bv Nährfette mit verbesserter verdaulichkeit
CZ288343B6 (en) * 1994-03-01 2001-05-16 Procter & Gamble Absorption core and sanitary towel
EP0739589B1 (de) * 1995-04-28 2001-06-13 Loders Croklaan B.V. An polyungesättigten Fettsäuren reiche Triglyceride
US6410078B1 (en) 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
WO1997009978A1 (en) * 1995-09-13 1997-03-20 Morten Sloth Weidner Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
ES2937137T3 (es) 2018-12-17 2023-03-24 Nestle Sa Butirato dietético

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE407180C (de) * 1920-04-25 1924-12-09 Wilhelm Normann Dr Verfahren zur Herstellung von gemischten Glyceriden
US2879281A (en) * 1955-06-29 1959-03-24 Eastman Kodak Co Trans esterification of triglycerides by means of plural metal catalyst
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
JPS6387988A (ja) * 1986-10-01 1988-04-19 Nisshin Oil Mills Ltd:The 消化吸収性の良い油脂
FR2617161B1 (fr) * 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention

Also Published As

Publication number Publication date
AU638541B2 (en) 1993-07-01
DK0509009T3 (da) 1995-08-07
EP0509009A1 (de) 1992-10-21
AU7046691A (en) 1991-07-24
CA2072010A1 (en) 1991-06-23
DK657689D0 (da) 1989-12-22
EP0509009B1 (de) 1995-04-19
JPH05502669A (ja) 1993-05-13
DE69018836T2 (de) 1995-11-16
DE69018836D1 (de) 1995-05-24
WO1991009597A1 (en) 1991-07-11

Similar Documents

Publication Publication Date Title
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
ES2054842T3 (es) Analogo del factor viii, procedimiento de preparacion y composicion farmaceutica que lo contiene.
MX9305444A (es) Derivados de rodanina como agentes hipoglucemicos y para el tratamiento de la enfermedad de alzheimer, composiciones farmaceuticas que los contienen y procedimiento para su preparacion.
ES2143122T3 (es) Sulfonimidamidas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ATE121293T1 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ES2133285T3 (es) Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.
FR2651435B1 (de)
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
ES2060293T3 (es) Nueva sustancia antiulcerosa.
ES2087279T3 (es) El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.
ES2037278T3 (es) Tratamiento de la esterilidad.
ES2089157T3 (es) Nuevos derivados de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
AT399504B (de) Neue aminopropoxyimino-cycloalkanderivate, deren herstellung, arzneimittel, die diese verbindungen als wirkstoff enthalten sowie verfahren zur herstellung derselben
ATE4988T1 (de) Antibiotika, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2644459B1 (fr) Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
GR3005231T3 (de)
ES2058770T3 (es) Nitroanilidas de acidos 1-metoxi-pirimidinil-1h-1,2,4-triazol-3-sulfonicos, procedimiento para su preparacion y su utilizacion como agentes con efecto herbicida.
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2055421T3 (es) Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.